Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Press Releases
Donate Now
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

 From
To
  • Default content image

    Michael J. Fox Foundation Honors Andres Lozano, MD, PhD, with Bachmann-Strauss Prize for Excellence in Dystonia Research

    NEW YORK (November 13, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced Andres Lozano, MD, PhD, professor of neurosurgery at the University of Toronto and Toronto…
    Learn more
  • Default content image

    Michael J. Fox Foundation Honors Ken Marek, MD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research

    NEW YORK (November 13, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2017 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Ken Marek, MD,…
    Learn more
  • Default content image

    Enrollment Now Open for The Michael J. Fox Foundation Phase IIa Clinical Trial Investigating Nilotinib in Parkinson's Disease

    Enrollment will open on an ongoing basis at a maximum of 25 clinical sites across the United States Visit foxtrialfinder.org for a list of currently recruiting sites and eligibility criteria Patients…
    Learn more
  • Default content image

    Michael J. Fox Foundation and 23andMe Announce Collaboration to Capture Parkinson's Experience at Scale and Amplify Patient Voice in Research and Care

    Fox Insight online digital platform facilitates partnership between patients and researchers to accelerate improved Parkinson's treatments and care Collaboration with 23andMe marries genetic and…
    Learn more
  • Default content image

    Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases

    NEW YORK (October 24, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium today announce a funding partnership to accelerate development of novel positron…
    Learn more
  • Default content image

    Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in Parkinson's Disease

    Trial aims to establish safety of long-term nilotinib use in people with Parkinson's disease; recruitment to begin in September 2017 Endpoints to include symptomatic response and biological measures…
    Learn more
  • Default content image

    Michael J. Fox Foundation and CASIS Announce Partnership to Grow Key Parkinson's Protein on International Space Station

    LRRK2 protein part of SpaceX cargo resupply mission scheduled for August 10 Microgravity conditions allow for larger and better formed protein crystals Better crystals may provide a higher…
    Learn more
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year